ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025
ProPhase Labs (NASDAQ: PRPH), a biotech, genomics and consumer products company, has scheduled a virtual conference call to present its full year 2024 financial results on March 31, 2025, at 11:00 AM EST. The presentation, hosted by Renmark Financial, will include the company's financial performance and a review of current company strategy.
A press release containing detailed financial results will be issued before the virtual conference call. Stakeholders, investors, and other interested parties are invited to register and attend the live event through Renmark Financial's platform. A replay of the presentation will be made available on ProPhase's investor website following the event.
ProPhase Labs (NASDAQ: PRPH), un'azienda biotech, genomica e di prodotti per consumatori, ha programmato una conferenza telefonica virtuale per presentare i suoi risultati finanziari dell'anno completo 2024 il 31 marzo 2025, alle 11:00 AM EST. La presentazione, ospitata da Renmark Financial, includerà le performance finanziarie dell'azienda e una revisione della strategia attuale.
Un comunicato stampa contenente i risultati finanziari dettagliati sarà emesso prima della conferenza telefonica virtuale. Stakeholder, investitori e altre parti interessate sono invitati a registrarsi e partecipare all'evento dal vivo attraverso la piattaforma di Renmark Financial. Una registrazione della presentazione sarà resa disponibile sul sito web degli investitori di ProPhase dopo l'evento.
ProPhase Labs (NASDAQ: PRPH), una empresa de biotecnología, genómica y productos de consumo, ha programado una conferencia telefónica virtual para presentar sus resultados financieros del año completo 2024 el 31 de marzo de 2025, a las 11:00 AM EST. La presentación, organizada por Renmark Financial, incluirá el desempeño financiero de la empresa y una revisión de la estrategia actual de la compañía.
Se emitirá un comunicado de prensa que contendrá los resultados financieros detallados antes de la conferencia telefónica virtual. Las partes interesadas, inversores y otros interesados están invitados a registrarse y asistir al evento en vivo a través de la plataforma de Renmark Financial. Una grabación de la presentación estará disponible en el sitio web de inversores de ProPhase después del evento.
ProPhase Labs (NASDAQ: PRPH), 생명공학, 유전체학 및 소비자 제품 회사는 2025년 3월 31일 오전 11시(동부 표준시)에 2024 회계연도 전체 재무 결과를 발표하기 위한 가상 회의 전화를 예정했습니다. Renmark Financial이 주최하는 이 발표에서는 회사의 재무 성과와 현재의 회사 전략에 대한 검토가 포함될 것입니다.
가상 회의 전화 전에 자세한 재무 결과를 포함한 보도 자료가 발행될 예정입니다. 이해관계자, 투자자 및 기타 관심 있는 당사자들은 Renmark Financial 플랫폼을 통해 라이브 이벤트에 등록하고 참석하도록 초대됩니다. 이벤트 후 ProPhase의 투자자 웹사이트에서 발표의 재생이 제공될 것입니다.
ProPhase Labs (NASDAQ: PRPH), une entreprise de biotechnologie, de génomique et de produits de consommation, a prévu une conférence téléphonique virtuelle pour présenter ses résultats financiers de l'année complète 2024 le 31 mars 2025 à 11h00 EST. La présentation, animée par Renmark Financial, comprendra la performance financière de l'entreprise et un examen de la stratégie actuelle de l'entreprise.
Un communiqué de presse contenant des résultats financiers détaillés sera publié avant la conférence téléphonique virtuelle. Les parties prenantes, les investisseurs et d'autres personnes intéressées sont invités à s'inscrire et à assister à l'événement en direct via la plateforme de Renmark Financial. Un enregistrement de la présentation sera mis à disposition sur le site des investisseurs de ProPhase après l'événement.
ProPhase Labs (NASDAQ: PRPH), ein Unternehmen für Biotechnologie, Genomik und Verbraucherprodukte, hat eine virtuelle Telefonkonferenz angesetzt, um seine finanziellen Ergebnisse für das Gesamtjahr 2024 am 31. März 2025 um 11:00 Uhr EST zu präsentieren. Die Präsentation, die von Renmark Financial veranstaltet wird, umfasst die finanzielle Leistung des Unternehmens und eine Übersicht über die aktuelle Unternehmensstrategie.
Eine Pressemitteilung mit detaillierten finanziellen Ergebnissen wird vor der virtuellen Telefonkonferenz veröffentlicht. Stakeholder, Investoren und andere interessierte Parteien sind eingeladen, sich zu registrieren und an der Live-Veranstaltung über die Plattform von Renmark Financial teilzunehmen. Eine Wiederholung der Präsentation wird nach der Veranstaltung auf der Investorenseite von ProPhase verfügbar sein.
- None.
- None.
GARDEN CITY, NY, March 27, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, today announced that they will be presenting full year 2024 financial results, and a review of current Company strategy, on a virtual conference call hosted by Renmark Financial on March 31, 2025 at 11:00 AM EST. A press release detailing these results will be issued prior to the virtual conference call. ProPhase Labs Inc. welcomes stakeholders, investors, and other individual followers to register and attend this live event.
Investors interested in participating in this live event will need to register using the link below. After the event, a replay will be available on the company’s investor website.
REGISTER HERE: https://www.renmarkfinancial.com/events/fourth-quarter-year-end-2024-results-virtual-conference-call-nasdaq-prph-PA3S8FxovQ
- To ensure smooth connectivity, please access this link using the latest version of Google Chrome.
About ProPhase Labs
ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and consumer products company. Our goal is to create a healthier world with bold action and the power of insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs’ valuable subsidiaries, their synergies, and significant growth underscore our potential for long-term value.
Media Relations and Institutional Investor Contact:
ProPhase Labs, Inc.
investorrelations@prophaselabs.com
Retail Investor Relations Contact:
Renmark Financial Communications
John Boidman
212-812-7680
Jboidman@renmarkfinancial.com
FAQ
When will ProPhase Labs (PRPH) release its 2024 annual financial results?
How can investors attend ProPhase Labs' (PRPH) 2024 financial results presentation?
Will there be a replay available of ProPhase Labs' (PRPH) 2024 financial results call?
What topics will be covered in ProPhase Labs' (PRPH) March 31 presentation?
